Diabetes is characterised by abnormally high blood glucose levels, excessive urination and persistent thirst and becomes more severe over time, making it more difficult for the patient to manage blood sugar levels. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been known to grant patients more control in lowering of blood sugar.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BHi4YpK
No comments:
Post a Comment